This chapter aligns with SDG goal 3 (good health and wellbeing) by fostering diverse perspectives within gastroenterology, which can lead to more comprehensive and inclusive healthcare approaches, and SDG goal 5 (gender equality) by promoting gender equality, leadership, and inclusivity in the field, encouraging increased representation and empowerment of women in gastroenterology.

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by discussing the roles of Tau, glial, and amyloid (A) in Alzheimer's Disease development.

This Viewpoint supports SDG 3 by highlighting the pervasive issues within health systems rooted in ableism and proposes an agenda to tackle ableism, aiming to make health systems responsive to the needs of people with disabilities.

This study investigates the therapeutic potential of nervonic acid (NA) in alleviating stroke-induced brain damage and post-stroke depression behaviors in rats, revealing that NA can improve neurological recovery, reduce infarct volume, and enhance depressive-like behaviors by modulating gut microbiota and metabolite activity. The findings suggest that NA could be a promising treatment option for stroke and associated post-stroke depression.

The annual observance of the International Day of Disabled Persons was proclaimed in 1992, by the United Nations General Assembly resolution 47/3.

This content aligns with Goal 3: Good Health and Goal 5: Gender Equity by examining the particular impact of climate change on women in South Asia.